Table 2.
Patients with survival at 3-months (n = 138) | Patients who died at 3-months (n = 14) | P | |
---|---|---|---|
Baseline characteristics | |||
Age [years] | 82 ± 5.3 | 81.8 ± 6.9 | 0.919 |
Sex (female) | 39.9% (n = 55) | 57.1% (n = 8) | 0.259 |
Weight [kg] | 77.8 ± 13.9 | 69.14 ± 13.5 | 0.027 |
Ideal weight [kg] | 62.4 ± 7.3 | 60.1 ± 8.3 | 0.282 |
Height [cm] | 167.4 ± 9.5 | 164.5 ± 10.6 | 0.291 |
BMI [kg/m2] | 27.2 (18.1–41.7) | 25.1 (16.4–37.4) | 0.133 |
Albumin [g/dL] | 4.2 (2.7–5) | 3.7 (2.5–4.8) | 0.018 |
GNRI | 113.6 ± 11.8 | 104 ± 9.6 | 0.004 |
Frailty | 66.7% (n = 92) | 85.7% (n = 12) | 0.227 |
Chronic renal failure | 96.4% (n = 133) | 100% (n = 14) | 0.999 |
Carotid occlusive disease | 18.1% (n = 25) | 21.4% (n = 3) | 0.723 |
Peripheral artery disease | 15.9% (n = 22) | 7.1% (n = 1) | 0.696 |
Previous cardiac surgery | 14.5% (n = 20) | 0% (n = 0) | 0.217 |
Previous MI | 10.1% (n = 14) | 14.3% (n = 2) | 0.644 |
Previous stroke | 13.8% (n = 19) | 14.3% (n = 2) | 0.999 |
Previous TIA | 1.4% (n = 2) | 7.1% (n = 1) | 0.253 |
Coronary artery disease | 60% (n = 80) | 57.1% (n = 8) | |
Porcelain aorta | 18.1% (n = 25) | 7.1% (n = 1) | 0.466 |
COPD | 15.2% (n = 21) | 21.4% (n = 3) | 0.465 |
Diabetes | 35.5% (n = 49) | 28.6% (n = 4) | 0.772 |
Hypertension | 93.5% (n = 129) | 85.7% (n = 12) | 0.268 |
EuroSCORE II | 5.5 ± 6.2 | 4.3 ± 4.5 | 0.482 |
STS score | 4.0 ± 2.7 | 4.6 ± 3.1 | 0.486 |
Procedural characteristics | |||
Type of valve: | |||
Portico | 71.4% | 84.6% | |
Evolut | 12.5% | 7.7% | |
Symetis | 0% | 7.7% | |
Sapien | 3 | 16.1% | 0% |
Contrast dye [mL] (n = 150) | 140 (10–550) | 185 (110–270) | 0.096 |
Fluoroscopy time [min] (n = 149) | 18.1 (7.9–230) | 20.6 (12.7–47) | 0.138 |
Simultaneous PCI (n = 150) | 2.2% (n = 3) | 7.7% (n = 1) | 0.327 |
Bold figures show significant differences; BMI — body mass index; COPD — chronic obstructive pulmonary disease; MI — myocardial infarction; PCI — percutaneous coronary intervention; TIA — transient ischemic attack